T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWOU
2701
DELISTED
2U Inc
TWOU
| $141K | ﹤0.01% |
12,058
+8,427
| +232% | +$164K |
|
2702
Farmers National Banc Corp
FMNB
$966M
| $140K | ﹤0.01% |
+10,431
| New | +$141K |
|
|
SLRN
2703
DELISTED
ACELYRIN
SLRN
| $140K | ﹤0.01% |
+20,703
| New | +$157K |
|
|
IVAC
2704
DELISTED
Intevac Inc
IVAC
| $140K | ﹤0.01% |
36,343
+497
| +1% | +$1.99K |
|
|
ZOM
2705
DELISTED
Zomedica Corp.
ZOM
| $139K | ﹤0.01% |
948,300
+276,100
| +41% | +$38.6K |
|
2706
Summit Therapeutics
SMMT
$11.7B
| $138K | ﹤0.01% |
33,145
+5,139
| +18% | +$20.4K |
|
2707
Aclaris Therapeutics
ACRS
$877M
| $137K | ﹤0.01% |
109,767
+1,252
| +1% | +$1.49K |
|
|
NAGE
2708
Niagen Bioscience
NAGE
$239M
| $137K | ﹤0.01% |
39,300
| – | – |
|
|
TERN
2709
DELISTED
Terns Pharmaceuticals
TERN
| $136K | ﹤0.01% |
20,694
+2,261
| +12% | +$14.8K |
|
2710
Upland Software
UPLD
$17.9M
| $136K | ﹤0.01% |
4,400
-385
| -8% | -$13.9K |
|
2711
Butterfly Network
BFLY
$2.46B
| $135K | ﹤0.01% |
124,384
+8,684
| +8% | +$9.31K |
|
|
MCW
2712
DELISTED
Mister Car Wash
MCW
| $135K | ﹤0.01% |
17,332
+2,479
| +17% | +$20.4K |
|
2713
Nano X Imaging
NNOX
$75M
| $135K | ﹤0.01% |
13,716
+1,612
| +13% | +$12.9K |
|
2714
SGHC Ltd
SGHC
$6.64B
| $135K | ﹤0.01% |
39,112
+4,715
| +14% | +$15.1K |
|
2715
Beam Global
BEEM
$25.8M
| $134K | ﹤0.01% |
19,600
| – | – |
|
2716
Cricut
CRCT
$1.23B
| $134K | ﹤0.01% |
28,008
+8,077
| +41% | +$43K |
|
2717
ARKO Corp
ARKO
$496M
| $133K | ﹤0.01% |
23,216
+3,092
| +15% | +$22.6K |
|
|
OPTU
2718
Optimum Communications Inc
OPTU
$229M
| $133K | ﹤0.01% |
50,700
-9,431
| -16% | -$23.7K |
|
|
TSE
2719
DELISTED
Trinseo
TSE
| $132K | ﹤0.01% |
34,906
+10,036
| +40% | +$53.6K |
|
2720
XPeng
XPEV
$11.2B
| $131K | ﹤0.01% |
17,000
| – | – |
|
|
GLDD
2721
DELISTED
Great Lakes Dredge & Dock
GLDD
| $130K | ﹤0.01% |
14,802
| – | – |
|
2722
Planet Labs
PL
$8.84B
| $130K | ﹤0.01% |
50,678
+6,215
| +14% | +$14K |
|
2723
Spruce Power Holding Corp
SPRU
$32.1M
| $130K | ﹤0.01% |
32,637
| – | – |
|
2724
Teekay
TK
$1.06B
| $130K | ﹤0.01% |
17,814
+1,747
| +11% | +$13.7K |
|
2725
UNIFI
UFI
$125M
| $129K | ﹤0.01% |
21,432
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.